1. Hyman L, Wu SY, Connell AM, et al. Prevalence and causes of visual impairment in The Barbados Eye Study. Ophthalmology. 2001; 108:1751–1756.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262–267.
Article
3. Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol. 1969; 53:721–748.
Article
4. Duijm HF, van den Berg TJ, Greve EL. Choroidal haemodynamics in glaucoma. Br J Ophthalmol. 1997; 81:735–742.
Article
5. Grunwald JE, Piltz J, Hariprasad SM, DuPont J. Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci. 1998; 39:2329–2336.
6. Schulzer M. Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group. Ophthalmology. 1992; 99:1468–1470.
7. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120:1268–1279.
8. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120:701–713. discussion 829-30.
9. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003; 121:48–56.
10. Shaarawy T, Sherwood M, Hitchings R, Crowston J. Galucoma. 2nd ed. London: Elsevier Saunders;2015. Vol. 1:p. 57–66.
11. Mwanza JC, Hochberg JT, Banitt MR, et al. Lack of association between glaucoma and macular choroidal thickness measured with enhanced depth-imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2011; 52:3430–3435.
Article
12. Kim M, Kim SS, Kwon HJ, et al. Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci. 2012; 53:7710–7717.
Article
13. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146:496–500.
Article
14. Barbosa CP, Stefanini FR, Penha F, et al. Intraocular pressure and ocular perfusion during hemodialysis. Arq Bras Oftalmol. 2011; 74:106–109.
Article
15. Schmidl D, Weigert G, Dorner GT, et al. Role of adenosine in the control of choroidal blood flow during changes in ocular perfusion pressure. Invest Ophthalmol Vis Sci. 2011; 52:6035–6039.
Article
16. Cashwell LF, Martin CA. Axial length decrease accompanying successful glaucoma filtration surgery. Ophthalmology. 1999; 106:2307–2311.
Article
17. Uretmen O, Ateş H, Andaç K, Deli B. Axial length changes accompanying successful nonpenetrating glaucoma filtration surgery. Ophthalmologica. 2003; 217:199–203.
Article
18. Németh J, Horóczi Z. Changes in the ocular dimensions after trabeculectomy. Int Ophthalmol. 1992; 16:355–357.
Article
19. Kook MS, Kim HB, Lee SU. Short-term effect of mitomycin-C augmented trabeculectomy on axial length and corneal astigmatism. J Cataract Refract Surg. 2001; 27:518–523.
Article
20. Berisha F, Schmetterer K, Vass C, et al. Effect of trabeculectomy on ocular blood flow. Br J Ophthalmol. 2005; 89:185–188.
Article
21. Yamazaki Y, Hayamizu F. Effect of trabeculectomy on retrobulbar circulation and visual field progression in patients with primary open-angle glaucoma. Clin Ophthalmol. 2012; 6:1539–1545.
Article
22. Kara N, Baz O, Altan C, et al. Changes in choroidal thickness, axial length, and ocular perfusion pressure accompanying successful glaucoma filtration surgery. Eye (Lond). 2013; 27:940–945.
Article
23. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002; 21:359–393.
Article
24. Bayhan HA, Bayhan SA, Can I. Evaluation of the macular choroidal thickness using spectral optical coherence tomography in pseudoexfoliation glaucoma. J Glaucoma. 2016; 25:184–187.
Article
25. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010; 29:144–168.
Article
26. Polska E, Simader C, Weigert G, et al. Regulation of choroidal blood flow during combined changes in intraocular pressure and arterial blood pressure. Invest Ophthalmol Vis Sci. 2007; 48:3768–3774.
Article
27. Saeedi O, Pillar A, Jefferys J, et al. Change in choroidal thickness and axial length with change in intraocular pressure after trabeculectomy. Br J Ophthalmol. 2014; 98:976–979.
Article
28. Maul EA, Friedman DS, Chang DS, et al. Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology. 2011; 118:1571–1579.
29. Sızmaz S, Küçükerdönmez C, Pınarci EY, et al. The effect of smoking on choroidal thickness measured by optical coherence tomography. Br J Ophthalmol. 2013; 97:601–604.
Article
30. Moschos MM, Nitoda E, Laios K, et al. The impact of chronic tobacco smoking on retinal and choroidal thickness in greek population. Oxid Med Cell Longev. 2016; 2016:2905789.
Article
31. Leske MC. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr Opin Ophthalmol. 2009; 20:73–78.
Article
32. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009; 147:811–815.
Article
33. Agawa T, Miura M, Ikuno Y, et al. Choroidal thickness measurement in healthy Japanese subjects by three-dimensional high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2011; 249:1485–1492.
Article
34. Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012; 53:261–266.
Article
35. Lee SW, Yu SY, Seo KH, et al. Diurnal variation in choroidal thickness in relation to sex, axial length, and baseline choroidal thickness in healthy Korean subjects. Retina. 2014; 34:385–393.
Article
36. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001; 108:1943–1953.
Article
37. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998; 126:487–497.
38. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000; 130:429–440.
39. Sanchez-Cano A, Orduna E, Sequra F, et al. Choroidal thickness and volume in healthy young white adults and the relationships between them and axial length, ammetropy and sex. Am J Ophthalmol. 2014; 158:574–583.
Article